Researcher, the discovery platform for academics and scientists, and Pharmaceutical Media Inc, (PMI), a leading sales firm specializing in representing medical publishers and professional medical organizations, today announce a partnership that will enable PMI to add Researcher’s innovative advertising products to the suite of channels it offers to businesses in the life sciences and publishing sectors.
Researcher is delighted to announce a new collaboration with Enago, https://www.enago.com/org/researcher/.
The explosion of data unleashed by the internet has had a significant impact on research in the 21st century. An interdisciplinary field called data science has emerged over the past few decades, bringing together statistics, engineering, maths, and computer science. Universities have established a vast range of data science programmes and faculties, but a lot of innovation is happening in the private sector. The availability of high-quality research has expanded - it can be found in preprints, conference proceedings, and even Medium blog posts, in addition to traditional peer-reviewed journals.
Join a panel discussion with data scientists from leading academic institutions and private companies to learn more about the state of data science research in the 21st century.
Our mission to ensure scientists and researchers never miss vital research is more important than ever with the world facing the huge challenge of the COVID-19 pandemic. This challenge can only be solved through the work of scientists, academics, clinicians and economists across the world.
Researcher is launching the COVID-19 International Research Collaboration (CIRC) – a dedicated zone on the Researcher platform that provides the easiest way to follow the latest science on COVID-19.
If you’re a scientist, researcher, doctor, engineer, economist, journalist working on responses to COVID-19 - or perhaps you’re just interested - we want to make sure that staying up to the minute with the latest research and papers about COVID-19 is as easy as possible.
We want to make sure you never miss important papers that could change the course of your work and accelerate a breakthrough that could change lives - so we’re creating a series of resources to help you:
- We created The COVID-19 International Research Collaboration (CIRC). CIRC aggregates the papers that have the most engagement from the highest quality users on Researcher. The papers are split into the following themes: Vaccine, Drugs, Treatment, Drug Pathways, Sequencing, Economic Impact, Social Impact and Epidemiology.
As part of our Global Researchers series we’ve been in contact with Researcher users to learn more about their research, the challenges they face, and what benefits they’ve derived from Researcher.
Speaking with researchers to understand the reasoning behind their research is instrumental for publishers. These small insights aid the publishers of the paper in understanding how they affect the day to day lives of researchers, their colleagues and their research.
Researcher, a discovery platform for academics and scientists, has announced a new project, ‘ReviewHub: reinventing peer review in the digital age’. It will be jointly funded by Researcher and a grant from Innovate UK, the UK’s innovation agency.
COVID-19 cases currently stand at over 445,000 worldwide. Now more than ever, scientists, researchers and publishers are working together to accelerate and distribute research that can contribute to the cessation of this pandemic.
Since mid-January 2020, there has been a rapid increase in the amount of papers relating to coronaviruses as a collective, and COVID-19. As of 17/03/2020 there have been a total of 1,882 COVID-19 related paper abstracts published across 530 different journals on Researcher.
Why do researchers do their research and how did they arrive at their academic niche? As part of our ‘Featured Authors’ series, we previously spoke with Alison Heard from the University of Calgary who discussed her paper as well as the challenges faced throughout the entire research, writing and publishing process.
As a speaker at the University of Oxford’s Curo-Pi3 conference in 2018, we interviewed Professor Rik Tykwinski. He shared his insights into what young academics and PhDs should do when attending academic conferences, what academics get up to when they attend international conferences, and how simple curiosity can be the driving force behind academic research.